N-(6,6-dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-3-methylbutanamide
PHA-793887 has been used in trials studying the treatment of Advanced/Metastatic Solid Tumors.